{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:57:38Z","timestamp":1793350658193,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA046049-01A1S1"],"award-info":[{"award-number":["R01DA046049-01A1S1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA023356"],"award-info":[{"award-number":["T32DA023356"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA046049-01A1S1"],"award-info":[{"award-number":["R01DA046049-01A1S1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA046049-01A1S1"],"award-info":[{"award-number":["R01DA046049-01A1S1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA046049-01A1S1"],"award-info":[{"award-number":["R01DA046049-01A1S1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"USC Institute for Addiction Science","award":["PG1033682"],"award-info":[{"award-number":["PG1033682"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01223-x","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T07:20:15Z","timestamp":1747639215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["\u201cYou don\u2019t have the right resources to let it hurt\u201d: How structural vulnerabilities shape opioid withdrawal experiences among a community sample of people who inject drugs in Los Angeles, California"],"prefix":"10.1186","volume":"22","author":[{"given":"Siddhi S.","family":"Ganesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca P.","family":"Smeltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse L.","family":"Goldshear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimi","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Carmen","family":"Ceasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky N.","family":"Bluthenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"1223_CR1","doi-asserted-by":"publisher","first-page":"107932","DOI":"10.1016\/j.drugalcdep.2020.107932","volume":"211","author":"RN Bluthenthal","year":"2020","unstructured":"Bluthenthal RN, Simpson K, Ceasar RC, et al. Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs. Drug Alcohol Depend. 2020;211:107932.","journal-title":"Drug Alcohol Depend"},{"key":"1223_CR2","unstructured":"Shah M, Huecker MR. Opioid Withdrawal. In: StatPearls. Treasure Island (FL): StatPearls Publishing. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526012\/ (2025, accessed 25 February 2025)."},{"key":"1223_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12954-023-00893-9","volume":"20","author":"D Frank","year":"2023","unstructured":"Frank D, Elliott L, Cleland CM, et al. As safe as possible: a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids. Harm Reduct J. 2023;20:158.","journal-title":"Harm Reduct J"},{"key":"1223_CR4","doi-asserted-by":"publisher","first-page":"103348","DOI":"10.1016\/j.drugpo.2021.103348","volume":"98","author":"D Frank","year":"2021","unstructured":"Frank D. I\u2019m pretty sure it\u2019s either food poisoning or Covid-19\u2019: lived experience versus medical knowledge in diagnosing substance use problems. Int J Drug Policy. 2021;98:103348.","journal-title":"Int J Drug Policy"},{"key":"1223_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.drugalcdep.2018.06.010","volume":"190","author":"PJ Summers","year":"2018","unstructured":"Summers PJ, Hellman JL, MacLean MR, et al. Negative experiences of pain and withdrawal create barriers to abscess care for people who inject heroin. A mixed methods analysis. Drug Alcohol Depend. 2018;190:200\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"1223_CR6","unstructured":"Shah DB, Fichadia PA, Shah FH et al. Acute psychotic episode precipitated by opioid withdrawal in a case of bipolar I disorder. Cureus; 15: e45538."},{"key":"1223_CR7","unstructured":"Sharma S, Kumar P, Singh R et al. Psychotic symptoms in heroin withdrawal: A case report. Cureus; 13: e12620."},{"key":"1223_CR8","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1080\/10826084.2024.2306221","volume":"59","author":"KA Simpson","year":"2024","unstructured":"Simpson KA, Bolshakova M, Kirkpatrick MG, et al. Characterizing opioid withdrawal experiences and consequences among a community sample of people who use opioids. Subst Use Misuse. 2024;59:886\u201394.","journal-title":"Subst Use Misuse"},{"key":"1223_CR9","doi-asserted-by":"publisher","first-page":"102934","DOI":"10.1016\/j.drugpo.2020.102934","volume":"85","author":"PK Valente","year":"2020","unstructured":"Valente PK, Bazzi AR, Childs E, et al. Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast. Int J Drug Policy. 2020;85:102934.","journal-title":"Int J Drug Policy"},{"key":"1223_CR10","doi-asserted-by":"crossref","unstructured":"Frank D, Bennett AS, Cleland CM et al. \u2018I still can feel the sickness\u2019: withdrawal experiences of people on methadone maintenance treatment. J Subst Use Addict Treat 2024; 209616.","DOI":"10.1016\/j.josat.2024.209616"},{"key":"1223_CR11","doi-asserted-by":"publisher","first-page":"107625","DOI":"10.1016\/j.ypmed.2023.107625","volume":"176","author":"RA Rawson","year":"2023","unstructured":"Rawson RA, Erath TG, Clark HW. The fourth wave of the overdose crisis: examining the prominent role of psychomotor stimulants with and without Fentanyl. Prev Med. 2023;176:107625.","journal-title":"Prev Med"},{"key":"1223_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34:344\u201350.","journal-title":"Curr Opin Psychiatry"},{"key":"1223_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","volume":"71","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183\u20138.","journal-title":"Int J Drug Policy"},{"key":"1223_CR14","first-page":"59","volume":"105","author":"R McNeil","year":"2014","unstructured":"McNeil R, Small W, Wood E, et al. Hospitals as a `risk environment: an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs. Soc Sci Med 1982. 2014;105:59.","journal-title":"Soc Sci Med 1982"},{"key":"1223_CR15","doi-asserted-by":"publisher","first-page":"103206","DOI":"10.1016\/j.drugpo.2021.103206","volume":"94","author":"RA Pollini","year":"2021","unstructured":"Pollini RA, Paquette CE, Drvar T, et al. A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia. Int J Drug Policy. 2021;94:103206.","journal-title":"Int J Drug Policy"},{"key":"1223_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/08897077.2019.1671942","volume":"41","author":"R Simon","year":"2020","unstructured":"Simon R, Snow R, Wakeman S. Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study. Subst Abuse. 2020;41:519\u201325.","journal-title":"Subst Abuse"},{"key":"1223_CR17","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.amjmed.2011.12.017","volume":"125","author":"WN Southern","year":"2012","unstructured":"Southern WN, Nahvi S, Arnsten JH. Increased risk of mortality and readmission among patients discharged against medical advice. Am J Med. 2012;125:594\u2013602.","journal-title":"Am J Med"},{"key":"1223_CR18","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1007\/s11606-010-1371-4","volume":"25","author":"JM Glasgow","year":"2010","unstructured":"Glasgow JM, Vaughn-Sarrazin M, Kaboli PJ. Leaving against medical advice (AMA): risk of 30-day mortality and hospital readmission. J Gen Intern Med. 2010;25:926\u20139.","journal-title":"J Gen Intern Med"},{"key":"1223_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3109\/16066359.2015.1068301","volume":"24","author":"KT Phillips","year":"2016","unstructured":"Phillips KT. Barriers to practicing risk reduction strategies among people who inject drugs. Addict Res Theory. 2016;24:62\u20138.","journal-title":"Addict Res Theory"},{"key":"1223_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/01459740.2011.576725","volume":"30","author":"J Quesada","year":"2011","unstructured":"Quesada J, Hart LK, Bourgois P. Structural vulnerability and health: Latino migrant laborers in the united States. Med Anthropol. 2011;30:339\u201362.","journal-title":"Med Anthropol"},{"key":"1223_CR21","doi-asserted-by":"publisher","first-page":"160940691562142","DOI":"10.1177\/1609406915621420","volume":"14","author":"A Ellard-Gray","year":"2015","unstructured":"Ellard-Gray A, Jeffrey NK, Choubak M, et al. Finding the hidden participant: solutions for recruiting hidden, Hard-to-Reach, and vulnerable populations. Int J Qual Methods. 2015;14:1609406915621420.","journal-title":"Int J Qual Methods"},{"key":"1223_CR22","first-page":"449","volume":"29","author":"S Hanuman","year":"2021","unstructured":"Hanuman S, Vyas N. Race, place, and housing in Los Angeles. J Afford Hous Community Dev Law. 2021;29:449\u201392.","journal-title":"J Afford Hous Community Dev Law"},{"key":"1223_CR23","doi-asserted-by":"crossref","unstructured":"Frazier L, Cutter WB. Missing housing: how Los Angeles is wasting multifamily housing units in the midst of a housing crisis. Hous Policy Debate 2024; 1\u201324.","DOI":"10.1080\/10511482.2024.2321234"},{"key":"1223_CR24","doi-asserted-by":"publisher","unstructured":"Rovner M. (Dis)possession: the historic development of view park and Los Angeles\u2019 ongoing housing crisis. Crit Plan; 25. Epub ahead of print 2022. https:\/\/doi.org\/10.5070\/CP825051265","DOI":"10.5070\/CP825051265"},{"key":"1223_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/s12889-025-21626-6","volume":"25","author":"JL Goldshear","year":"2025","unstructured":"Goldshear JL, Ganesh SS, Borquez A, et al. Material hardship, forced displacement, and negative health outcomes among unhoused people who use drugs in Los Angeles, California and Denver, Colorado: a latent class analysis. BMC Public Health. 2025;25:591.","journal-title":"BMC Public Health"},{"key":"1223_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12939-023-01920-8","volume":"22","author":"LJ Avelar Portillo","year":"2023","unstructured":"Avelar Portillo LJ, Kayser GL, Ko C, et al. Water, sanitation, and hygiene (WaSH) insecurity in unhoused communities of Los Angeles, California. Int J Equity Health. 2023;22:108.","journal-title":"Int J Equity Health"},{"key":"1223_CR27","unstructured":"de la Haye K, Miller S, Livings M et al. The Impact of COVID-19 on Food Insecurity in Los Angeles County: April to July 2020, https:\/\/publicexchange.usc.edu\/wp-content\/uploads\/2021\/02\/USC_LAC_Food_Insecurity_Report_April-July_2020.pdf (2020, accessed 25 February 2025)."},{"key":"1223_CR28","doi-asserted-by":"publisher","first-page":"107323","DOI":"10.1016\/j.appet.2024.107323","volume":"198","author":"JJ Scott","year":"2024","unstructured":"Scott JJ, Bruine de Bruin W, Rabinovich L, et al. Understanding food insecurity in Los Angeles County during the COVID-19 pandemic and its aftermath: A qualitative interview study. Appetite. 2024;198:107323.","journal-title":"Appetite"},{"key":"1223_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.amepre.2024.06.016","volume":"67","author":"H Padwa","year":"2024","unstructured":"Padwa H, Chien J, Henwood BF, et al. Homelessness, discrimination, and violent victimization in Los Angeles County. Am J Prev Med. 2024;67:666\u201375.","journal-title":"Am J Prev Med"},{"key":"1223_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1353\/hpu.2007.0011","volume":"18","author":"KC Heslin","year":"2007","unstructured":"Heslin KC, Robinson PL, Baker RS, et al. Community characteristics and violence against homeless women in Los Angeles County. J Health Care Poor Underserved. 2007;18:203\u201318.","journal-title":"J Health Care Poor Underserved"},{"key":"1223_CR31","unstructured":"Ganesh S, Erin EG, D AJ et al. I\u2019m scared to death of that Fentanyl: Disruption of the Illicit Opioid Supply as a Driver of Structural Disempowerment."},{"key":"1223_CR32","doi-asserted-by":"crossref","unstructured":"Goldshear JL, Corsi KF, Ceasar RC et al. Housing and Displacement as Risk Factors for Negative Health Outcomes Among People Who Inject Drugs in Los Angeles, CA, and Denver, CO, USA. Res Sq. 2024; rs.3.rs-4758949.","DOI":"10.21203\/rs.3.rs-4758949\/v1"},{"key":"1223_CR33","unstructured":"Los Angeles County Department of Public Health, Center for Health Impact Evaluation. Mortality Rates and Causes of Death Among People Experiencing Homelessness in Los Angeles County: 2014\u20132022. March 2024."},{"key":"1223_CR34","doi-asserted-by":"publisher","first-page":"100257","DOI":"10.1016\/j.dadr.2024.100257","volume":"12","author":"SS Ganesh","year":"2024","unstructured":"Ganesh SS, Gould EE, Conner BT, et al. Smoking weed it gets you over the hump: Cannabis co-use as a facilitator of decreased opioid use among people who inject drugs in Los Angeles, California. Drug Alcohol Depend Rep. 2024;12:100257.","journal-title":"Drug Alcohol Depend Rep"},{"key":"1223_CR35","unstructured":"IBM SPSS Statistics. https:\/\/www.ibm.com\/products\/spss-statistics\/var?adoper=265413_1&lot=5&mhsrc=ibmsearch_a&mhq=spss&alloy_redirect=eyJ2IjoxLCJhZCI6IjI2Mjk3MDowOjB8MiJ9 (accessed 25 February 2025)."},{"key":"1223_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1080\/14659891.2023.2288839","volume":"30","author":"RC Ceasar","year":"2025","unstructured":"Ceasar RC, Goldshear JL, Simpson KA, et al. Trends in COVID-19 testing, infection, vaccination, and housing assistance among people who inject drugs in Los Angeles and Denver. J Subst Use. 2025;30:110\u20136.","journal-title":"J Subst Use"},{"key":"1223_CR37","unstructured":"Handley M, Pasick R, Potter M et al. Community-Engaged Research: A Quick-Start Guide for Researchers. https:\/\/accelerate.ucsf.edu\/sites\/default\/files\/CE\/guide_for_researchers.pdf (2010, accessed 25 February 2025)."},{"key":"1223_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.drugalcdep.2017.04.001","volume":"175","author":"RN Bluthenthal","year":"2017","unstructured":"Bluthenthal RN, Wenger L, Chu D, et al. Drug use generations and patterns of injection drug use: birth cohort differences among people who inject drugs in Los Angeles and San Francisco, California. Drug Alcohol Depend. 2017;175:210\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"1223_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/01.ALC.0000156118.74728.34","volume":"29","author":"RN Bluthenthal","year":"2005","unstructured":"Bluthenthal RN, Browntaylor D, Guzm\u00e1n-Becerra N, et al. Characteristics of malt liquor beer drinkers in a low-income, Racial minority community sample. Alcohol Clin Exp Res. 2005;29:402\u20139.","journal-title":"Alcohol Clin Exp Res"},{"key":"1223_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/0739986319845103","volume":"41","author":"P Escobedo","year":"2019","unstructured":"Escobedo P, Gonzalez KD, Kuhlberg J, et al. Community needs assessment among Latino families in an urban public housing development. Hisp J Behav Sci. 2019;41:344\u201362.","journal-title":"Hisp J Behav Sci"},{"key":"1223_CR41","first-page":"70","volume":"98","author":"SM Walters","year":"2021","unstructured":"Walters SM, Kral AH, Lamb S, et al. Correlates of transactional sex and violent victimization among men who inject drugs in Los Angeles and San Francisco, California. J Urban Health Bull N Y Acad Med. 2021;98:70\u201382.","journal-title":"J Urban Health Bull N Y Acad Med"},{"key":"1223_CR42","first-page":"469","volume":"96","author":"JE Williams","year":"2019","unstructured":"Williams JE, Dangerfield DT, Kral AH, et al. Correlates of sexual coercion among people who inject drugs (PWID) in Los Angeles and San Francisco, CA. J Urban Health Bull N Y Acad Med. 2019;96:469\u201376.","journal-title":"J Urban Health Bull N Y Acad Med"},{"key":"1223_CR43","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1080\/10826084.2019.1608252","volume":"54","author":"S Navarro","year":"2019","unstructured":"Navarro S, Kral AH, Strike CS, et al. Factors associated with frequency of recent initiation of others into injection drug use among people who inject drugs in Los Angeles and San Francisco, CA, USA, 2016-17. Subst Use Misuse. 2019;54:1715\u201324.","journal-title":"Subst Use Misuse"},{"key":"1223_CR44","first-page":"653","volume":"84","author":"RN Bluthenthal","year":"2007","unstructured":"Bluthenthal RN, Do DP, Finch B, et al. Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay area: A multilevel analysis. J Urban Health Bull N Y Acad Med. 2007;84:653\u201366.","journal-title":"J Urban Health Bull N Y Acad Med"},{"key":"1223_CR45","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/00042560-199808150-00013","volume":"18","author":"RN Bluthenthal","year":"1998","unstructured":"Bluthenthal RN, Kral AH, Erringer EA, et al. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. J Acquir Immune Defic Syndr Hum Retrovirology Off Publ Int Retrovirology Assoc. 1998;18:505\u201311.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirology Off Publ Int Retrovirology Assoc"},{"key":"1223_CR46","unstructured":"Cagle HH, Fisher DG, Senter TP et al. Classifying skin lesions of injection drug users: A Method for Corroborating Disease Risk."},{"key":"1223_CR47","unstructured":"Charmaz K. Constructing grounded theory: A practical guide through qualitative analysis. SAGE; 2006."},{"key":"1223_CR48","unstructured":"ATLAS.ti|. The #1 Software for Qualitative Data Analysis. ATLAS.ti. https:\/\/atlasti.com (accessed 25 February 2025)."},{"key":"1223_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/1077800416657105","volume":"23","author":"K Charmaz","year":"2017","unstructured":"Charmaz K. The power of constructivist grounded theory for critical inquiry. Qual Inq. 2017;23:34\u201345.","journal-title":"Qual Inq"},{"key":"1223_CR50","doi-asserted-by":"publisher","first-page":"160940691771935","DOI":"10.1177\/1609406917719350","volume":"16","author":"K Charmaz","year":"2017","unstructured":"Charmaz K. Special invited paper: continuities, contradictions, and critical inquiry in grounded theory. Int J Qual Methods. 2017;16:1609406917719350.","journal-title":"Int J Qual Methods"},{"key":"1223_CR51","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/1077800419879081","volume":"26","author":"K Charmaz","year":"2020","unstructured":"Charmaz K. With constructivist grounded theory you can\u2019t Hide: social justice research and critical inquiry in the public sphere. Qual Inq. 2020;26:165\u201376.","journal-title":"Qual Inq"},{"key":"1223_CR52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/ACM.0000000000001294","volume":"92","author":"P Bourgois","year":"2017","unstructured":"Bourgois P, Holmes SM, Sue K, et al. Structural vulnerability: operationalizing the concept to address health disparities in clinical care. Acad Med. 2017;92:299.","journal-title":"Acad Med"},{"key":"1223_CR53","doi-asserted-by":"publisher","first-page":"108681","DOI":"10.1016\/j.drugalcdep.2021.108681","volume":"222","author":"RN Bluthenthal","year":"2021","unstructured":"Bluthenthal RN. Structural racism and violence as social determinants of health: conceptual, methodological and intervention challenges. Drug Alcohol Depend. 2021;222:108681.","journal-title":"Drug Alcohol Depend"},{"key":"1223_CR54","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/ADM.0000000000001185","volume":"17","author":"HE Bird","year":"2023","unstructured":"Bird HE, Huhn AS, Dunn KE. Fentanyl absorption, distribution, metabolism, and excretion: narrative review and clinical significance related to illicitly manufactured Fentanyl. J Addict Med. 2023;17:503\u20138.","journal-title":"J Addict Med"},{"key":"1223_CR55","doi-asserted-by":"publisher","first-page":"109003","DOI":"10.1016\/j.drugalcdep.2021.109003","volume":"227","author":"AH Kral","year":"2021","unstructured":"Kral AH, Lambdin BH, Browne EN, et al. Transition from injecting opioids to smoking Fentanyl in San Francisco, California. Drug Alcohol Depend. 2021;227:109003.","journal-title":"Drug Alcohol Depend"},{"key":"1223_CR56","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.drugpo.2009.08.007","volume":"21","author":"P Mateu-Gelabert","year":"2010","unstructured":"Mateu-Gelabert P, Sandoval M, Meylakhs P, et al. Strategies to avoid opiate withdrawal: implications for HCV and HIV risks. Int J Drug Policy. 2010;21:179\u201385.","journal-title":"Int J Drug Policy"},{"key":"1223_CR57","doi-asserted-by":"crossref","unstructured":"Rafful C, Magis-Rodr\u00edguez C. The need for structural interventions for persons who misuse opioids. In: Cruz SL, editor Opioids: pharmacology, abuse, and addiction. Cham: Springer International Publishing, pp. 127\u201345.","DOI":"10.1007\/978-3-031-09936-6_7"},{"key":"1223_CR58","first-page":"168","volume":"133","author":"R McNeil","year":"2015","unstructured":"McNeil R, Kerr T, Anderson S, et al. Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study. Soc Sci Med 1982. 2015;133:168\u201376.","journal-title":"Soc Sci Med 1982"},{"key":"1223_CR59","doi-asserted-by":"publisher","first-page":"104574","DOI":"10.1016\/j.drugpo.2024.104574","volume":"133","author":"M Gibson","year":"2024","unstructured":"Gibson M. Putting the capital in recovery capital: an exploration of universal basic income and the impacts for people who use drugs in Canada. Int J Drug Policy. 2024;133:104574.","journal-title":"Int J Drug Policy"},{"key":"1223_CR60","doi-asserted-by":"publisher","first-page":"e242014","DOI":"10.1001\/jamahealthforum.2024.2014","volume":"5","author":"PJ Christine","year":"2024","unstructured":"Christine PJ, Goldman AL, Morgan JR, et al. Insurance instability for patients with opioid use disorder in the year after diagnosis. JAMA Health Forum. 2024;5:e242014.","journal-title":"JAMA Health Forum"},{"key":"1223_CR61","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/add.16383","volume":"119","author":"H Cooper","year":"2024","unstructured":"Cooper H, Beane S, Yarbrough C, et al. Association of medicaid expansion with health insurance, unmet need for medical care and substance use disorder treatment among people who inject drugs in 13 US States. Addiction. 2024;119:582\u201392.","journal-title":"Addiction"},{"key":"1223_CR62","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3109\/10826084.2015.1007669","volume":"50","author":"HL Cooper","year":"2015","unstructured":"Cooper HL. War on drugs policing and Police brutality. Subst Use Misuse. 2015;50:1188\u201394.","journal-title":"Subst Use Misuse"},{"key":"1223_CR63","unstructured":"Young J. Medicaid Eligibility for Incarcerated Individuals in California. https:\/\/healthlaw.org\/wp-content\/uploads\/2024\/11\/Medicaid-Eligibility-for-Incarcerated-Individuals-in-California_Nov-2024.pdf (2024)."},{"key":"1223_CR64","unstructured":"Baumrucker EP, Medicaid I, Individuals. https:\/\/crsreports.congress.gov\/product\/pdf\/if\/if11830 (2024)."},{"key":"1223_CR65","unstructured":"U.S. Centers for Medicare and Medicaid Services. Mental health & substance use disorders| Medicare. Medicare.gov. https:\/\/www.medicare.gov\/coverage\/mental-health-substance-use-disorder (accessed 25 February 2025)."},{"key":"1223_CR66","doi-asserted-by":"publisher","unstructured":"Steinberg D, Weber E, Woodworth A. Medicare\u2019s discriminatory coverage policies for substance use disorders. Health Aff Forefr. https:\/\/doi.org\/10.1377\/forefront.20210616.166523","DOI":"10.1377\/forefront.20210616.166523"},{"key":"1223_CR67","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1377\/hlthaff.2016.0623","volume":"35","author":"CM Grogan","year":"2016","unstructured":"Grogan CM, Andrews C, Abraham A, et al. Survey highlights differences in medicaid coverage for substance use treatment and opioid use disorder medications. Health Aff Proj Hope. 2016;35:2289\u201396.","journal-title":"Health Aff Proj Hope"},{"key":"1223_CR68","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/CXA.0000000000000167","volume":"14","author":"F Ali","year":"2023","unstructured":"Ali F, Russell C, Law J, et al. Withdrawal management practices and services in Canada: A Cross-Sectional National survey on the management of opioid use disorder. Can J Addict. 2023;14:6\u201314.","journal-title":"Can J Addict"},{"key":"1223_CR69","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s11606-020-06257-4","volume":"35","author":"K Mackey","year":"2020","unstructured":"Mackey K, Veazie S, Anderson J, et al. Barriers and facilitators to the use of medications for opioid use disorder: a rapid review. J Gen Intern Med. 2020;35:954\u201363.","journal-title":"J Gen Intern Med"},{"key":"1223_CR70","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jsat.2019.07.014","volume":"108","author":"K Darfler","year":"2020","unstructured":"Darfler K, Sandoval J, Pearce Antonini V, et al. Preliminary results of the evaluation of the California hub and spoke program. J Subst Abuse Treat. 2020;108:26\u201332.","journal-title":"J Subst Abuse Treat"},{"key":"1223_CR71","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/jamapsychiatry.2016.1390","volume":"73","author":"A Lembke","year":"2016","unstructured":"Lembke A, Chen JH. Use of opioid agonist therapy for medicare patients in 2013. JAMA Psychiatry. 2016;73:990\u20132.","journal-title":"JAMA Psychiatry"},{"key":"1223_CR72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/08897077.2015.1080208","volume":"37","author":"RM Burns","year":"2016","unstructured":"Burns RM, Pacula RL, Bauhoff S, et al. Policies related to opioid agonist therapy for opioid use disorders: the evolution of state policies from 2004 to 2013. Subst Abuse. 2016;37:63\u20139.","journal-title":"Subst Abuse"},{"key":"1223_CR73","doi-asserted-by":"publisher","first-page":"1141093","DOI":"10.3389\/fpubh.2023.1141093","volume":"11","author":"W Bremer","year":"2023","unstructured":"Bremer W, Plaisance K, Walker D, et al. Barriers to opioid use disorder treatment: A comparison of self-reported information from social media with barriers found in literature. Front Public Health. 2023;11:1141093.","journal-title":"Front Public Health"},{"key":"1223_CR74","doi-asserted-by":"publisher","unstructured":"McLean K, Murphy J, Kruis N. I think we\u2019re getting better but we\u2019re still not there: Provider-based stigma and perceived barriers to care for people who use opioids (PWUO). J Subst Use Addict Treat; 159. Epub ahead of print 1 April 2024. https:\/\/doi.org\/10.1016\/j.josat.2023.209270","DOI":"10.1016\/j.josat.2023.209270"},{"key":"1223_CR75","doi-asserted-by":"publisher","first-page":"S420","DOI":"10.1093\/infdis\/jiaa337","volume":"222","author":"R Lewis","year":"2020","unstructured":"Lewis R, Baugher AR, Finlayson T, et al. Healthcare access and utilization among persons who inject drugs in medicaid expansion and nonexpansion States: 22 united States cities, 2018. J Infect Dis. 2020;222:S420\u20138.","journal-title":"J Infect Dis"},{"key":"1223_CR76","first-page":"100029","volume":"2","author":"A Cernasev","year":"2021","unstructured":"Cernasev A, Hohmeier KC, Frederick K, et al. A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder. Explor Res Clin Soc Pharm. 2021;2:100029.","journal-title":"Explor Res Clin Soc Pharm"},{"key":"1223_CR77","doi-asserted-by":"publisher","first-page":"104567","DOI":"10.1016\/j.drugpo.2024.104567","volume":"132","author":"LM Harris","year":"2024","unstructured":"Harris LM, Guerrero EG, Khachikian T, et al. Expert providers implement integrated and coordinated care in opioid use disorder treatment. Int J Drug Policy. 2024;132:104567.","journal-title":"Int J Drug Policy"},{"key":"1223_CR78","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jsat.2019.07.013","volume":"108","author":"GM Miele","year":"2020","unstructured":"Miele GM, Caton L, Freese TE, et al. Implementation of the hub and spoke model for opioid use disorders in California: rationale, design and anticipated impact. J Subst Abuse Treat. 2020;108:20\u20135.","journal-title":"J Subst Abuse Treat"},{"key":"1223_CR79","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1007\/s11606-021-07344-w","volume":"37","author":"AP Nguyen","year":"2022","unstructured":"Nguyen AP, Glanz JM, Shoup JA, et al. Mortality among patients prescribed buprenorphine for opioid use disorder after disenrollment from an insurance plan and healthcare system. J Gen Intern Med. 2022;37:2882\u20134.","journal-title":"J Gen Intern Med"},{"key":"1223_CR80","doi-asserted-by":"publisher","first-page":"e224001","DOI":"10.1001\/jamahealthforum.2022.4001","volume":"3","author":"AJ Abraham","year":"2022","unstructured":"Abraham AJ, Andrews CM, Harris SJ, et al. Coverage and prior authorization policies for medications for opioid use disorder in medicaid managed care. JAMA Health Forum. 2022;3:e224001.","journal-title":"JAMA Health Forum"},{"key":"1223_CR81","doi-asserted-by":"publisher","first-page":"104645","DOI":"10.1016\/j.drugpo.2024.104645","volume":"134","author":"A McCracken","year":"2024","unstructured":"McCracken A, Brant K, Latkin C, et al. Tethered to this ball and chain: women\u2019s perspectives on bodily agency within opioid treatment programs. Int J Drug Policy. 2024;134:104645.","journal-title":"Int J Drug Policy"},{"key":"1223_CR82","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/10826084.2017.1310247","volume":"53","author":"D Frank","year":"2018","unstructured":"Frank D. I was not sick and I didn\u2019t need to recover\u2019: methadone maintenance treatment (MMT) as a refuge from criminalization. Subst Use Misuse. 2018;53:311\u201322.","journal-title":"Subst Use Misuse"},{"key":"1223_CR83","doi-asserted-by":"publisher","first-page":"102844","DOI":"10.1016\/j.drugpo.2020.102844","volume":"83","author":"D Frank","year":"2020","unstructured":"Frank D. Methadone maintenance treatment is swapping one drug for another, and that\u2019s why it works: towards a treatment-based critique of the war on drugs. Int J Drug Policy. 2020;83:102844.","journal-title":"Int J Drug Policy"},{"key":"1223_CR84","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/02791072.2020.1824046","volume":"53","author":"Frank PhD David","year":"2021","unstructured":"Frank PhD David. That\u2019s no longer tolerated: policing patients\u2019 use of non-opioid substances in methadone maintenance treatment. J Psychoact Drugs. 2021;53:10\u20137.","journal-title":"J Psychoact Drugs"},{"key":"1223_CR85","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.2105\/AJPH.2021.306665","volume":"112","author":"C Simon","year":"2022","unstructured":"Simon C, Vincent L, Coulter A, et al. The methadone manifesto: treatment experiences and policy recommendations from methadone patient activists. Am J Public Health. 2022;112:S117\u201322.","journal-title":"Am J Public Health"},{"key":"1223_CR86","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12954-024-01075-x","volume":"21","author":"M Bolshakova","year":"2024","unstructured":"Bolshakova M, Simpson KA, Ganesh SS, et al. The Fentanyl made me feel like I needed more methadone: changes in the role and use of medication for opioid use disorder (MOUD) due to Fentanyl. Harm Reduct J. 2024;21:156.","journal-title":"Harm Reduct J"},{"key":"1223_CR87","unstructured":"Bolshakova M, Simpson KA, Ganesh SS et al. Perspectives on medication for opioid use disorder (MOUD) access and service delivery among a community sample of people who use opioids in Los Angeles. J Subst Use Addict Treat."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01223-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01223-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01223-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:04:33Z","timestamp":1747641873000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01223-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1223"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01223-x","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University of Southern California Institutional Review Board (Study ID#: HS-18-00624). All study participants provided informed consent for participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}